Literature DB >> 3127417

Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency.

B Couzinet1, N Lestrat, S Brailly, M Forest, G Schaison.   

Abstract

According to the 2-cell theory, ovarian steroidogenesis requires the coordinate action of both FSH and LH. To evaluate the relative importance of these hormones in follicular maturation, a randomized cross-over study was performed in 10 women with complete gonadotropin deficiency (absence of pulsatile LH secretion and no LH response to LHRH). Five women were treated with highly purified FSH (LH bioactivity, 0.09%) and 3 months later with human menopausal gonadotropin (hMG; LH bioactivity, 65%), each given for 10 days at a daily dose of 225 IU FSH, im. The sequence was reversed in the other 5 women. hCG (5000 IU) was administered im 24 h after the last injection of FSH or hMG. Plasma estradiol (E2), estrone (E1), androstenedione (A), testosterone, LH, and FSH concentrations and urinary LH and FSH were measured daily by RIA. Ultrasonography was performed during each treatment and 2 days after each hCG injection. After FSH treatment, mean plasma and urinary FSH levels increased, mean plasma LH did not change, and urinary LH increased slightly but not significantly from 91 +/- 32 (SE) to 164 +/- 55 mIU/24 h (10(-3) IU/24 h). After hMG treatment, mean plasma and urinary LH and FSH levels increased accordingly. The mean basal plasma E2 [11 +/- 1 pg/mL (40 +/- 4 pmol/L)] and E1 [14 +/- 4 pg/mL (52 +/- 15 pmol/L)] levels increased after FSH treatment to 207 +/- 69 pg/mL (760 +/- 253 pmol/L) and 82 +/- 21 pg/mL (303 +/- 78 pmol/L), respectively (P less than 0.01), but plasma A did not change. In response to hMG, the mean plasma E2, E1, A, and testosterone levels increased more than during FSH treatment. Ultrasonography revealed multiple preovulatory follicles (greater than or equal to 16 mm) in 2 women after hMG and 1 woman after FSH treatment; therefore, hCG was not administered. In 3 women given FSH, hCG did not induce ovulation. hCG induced ovulation in 8 women given hMG and in 6 women given FSH, based on ultrasonography and plasma progesterone levels. Thus, in the presence of profound gonadotropin deficiency pharmacological doses of FSH, with minute LH contamination, are capable of stimulating ovarian follicular maturation, underlining the key role of FSH in folliculogenesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3127417     DOI: 10.1210/jcem-66-3-552

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

Review 1.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

2.  Influence of pituitary suppression with triphasic or monophasic oral contraceptives on the outcome of in vitro fertilization and embryo transfer.

Authors:  Ming-Ting Chung; Yung-Chieh Tsai; Sheng-Hsien Chen; Tao-Chuan Loo; Hsun-Han Tang; Liang-Yin Lin
Journal:  J Assist Reprod Genet       Date:  2006-08-16       Impact factor: 3.412

3.  Exogenous luteinizing hormone (LH) increases estradiol response patterns in poor responders with low serum LH concentrations.

Authors:  J Y Phelps; L Figueira-Armada; A S Levine; N P Vlahos; D Roshanfekr; H A Zacur; J E Garcia
Journal:  J Assist Reprod Genet       Date:  1999-08       Impact factor: 3.412

Review 4.  Are circulating gonadotropin isoforms naturally occurring biased agonists? Basic and therapeutic implications.

Authors:  Brian J Arey; Francisco J López
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

5.  Clinical and genetic analysis of an isolated follicle-stimulating hormone deficiency female patient.

Authors:  Lixia Zhu; Nan Xiao; Tao Zhang; Pingping Kong; Bei Xu; Zishui Fang; Lei Jin
Journal:  J Assist Reprod Genet       Date:  2020-05-05       Impact factor: 3.412

6.  Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol.

Authors:  J Balasch; F Fábregues; M Creus; R Casamitjana; B Puerto; J A Vanrell
Journal:  J Assist Reprod Genet       Date:  2000-11       Impact factor: 3.412

7.  Differences in serum LH and FSH levels using depot or daily GnRH agonists in controlled ovarian stimulation: influence on ovarian response and outcome of ART.

Authors:  Barbara Sonntag; Ludwig Kiesel; Eberhard Nieschlag; Hermann M Behre
Journal:  J Assist Reprod Genet       Date:  2005-08       Impact factor: 3.412

8.  Comparison of highly purified FSH (metrodin-high purity) with pergonal for IVF superovulation.

Authors:  J S Bagratee; G Lockwood; A López Bernal; D H Barlow; W L Ledger
Journal:  J Assist Reprod Genet       Date:  1998-02       Impact factor: 3.412

9.  Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients.

Authors:  J Balasch; F Fábregues; J Peñarrubia; M Creus; R Vidal; R Casamitjana; D Manau; J A Vanrell
Journal:  J Assist Reprod Genet       Date:  1998-10       Impact factor: 3.412

10.  Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review.

Authors:  Bernd Th Krause; Ralf Ohlinger; Annette Haase
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.